Assyro AI

Orange Book product · Brand (NDA)

DUOBRII

HALOBETASOL PROPIONATE; TAZAROTENE

Brand (NDA)NDA 209354TE ABRX BAUSCH

At a glance

Apr 25, 2019

Approved

Brand (NDA)

Application

AB

TE code

10

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 25, 2019

    7 yr 3 mo ago

  2. Today

  3. Patent 10478502 expires

    Listed drug product patent expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  4. Patent 11839656 expires

    Listed method-of-use patent (U-2625) expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  5. Patent 11957753 expires

    Listed drug product patent expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  6. Patent 11986527 expires

    Listed method-of-use patent (U-2625) expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  7. Patent 12076403 expires

    Listed drug product patent expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  8. Patent 8809307 expires

    Listed drug product patent expiration.

    Nov 02, 2031

    in 5 yr 5 mo

  9. Patent 10251895 expires

    Listed drug product patent expiration.

    Jun 06, 2036

    in 10 yr 1 mo

  10. Patent 10426787 expires

    Listed method-of-use patent (U-2625) expiration.

    Jun 06, 2036

    in 10 yr 1 mo

  11. Patent 11648256 expires

    Listed drug product patent expiration.

    Jun 06, 2036

    in 10 yr 1 mo

  12. Patent 11679115 expires

    Listed drug product patent expiration.

    Jun 06, 2036

    in 10 yr 1 mo

Pharmaceutical detail

Active ingredient

HALOBETASOL PROPIONATE; TAZAROTENE

Strength

0.01%;0.045%

Dosage form

LOTION

Route

TOPICAL

TE code

AB

Application

NDA 209354

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10478502Nov 02, 2031in 5 yr 5 mo
ProductU-2625
11839656Nov 02, 2031in 5 yr 5 mo
U-2625
11957753Nov 02, 2031in 5 yr 5 mo
Product
11986527Nov 02, 2031in 5 yr 5 mo
U-2625
12076403Nov 02, 2031in 5 yr 5 mo
Product
8809307Nov 02, 2031in 5 yr 5 mo
Product
10251895Jun 06, 2036in 10 yr 1 mo
Product
10426787Jun 06, 2036in 10 yr 1 mo
U-2625
11648256Jun 06, 2036in 10 yr 1 mo
ProductU-2625
11679115Jun 06, 2036in 10 yr 1 mo
ProductU-2625
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.